TY - JOUR
T1 - Intensive Ambulance-Delivered Blood-Pressure Reduction in Hyperacute Stroke
AU - Li, Gang
AU - Lin, Yapeng
AU - Yang, Jie
AU - Anderson, Craig S.
AU - Chen, Chen
AU - Liu, Feifeng
AU - Billot, Laurent
AU - Li, Qiang
AU - Chen, Xiaoying
AU - Liu, Xiaoqiu
AU - Ren, Xinwen
AU - Zhang, Chunfang
AU - Xu, Ping
AU - Wu, Lijun
AU - Wang, Feng
AU - Qiu, Daijun
AU - Jiang, Mei
AU - Peng, Yiqian
AU - Li, Chaohui
AU - Huang, Yiyang
AU - Zhao, Xiaohui
AU - Liang, Jiye
AU - Wang, Yao
AU - Wu, Xiangjun
AU - Xu, Xiaoyun
AU - Chen, Guofang
AU - Huang, Dongya
AU - Zhang, Yue
AU - Zuo, Lian
AU - Ma, Guozhao
AU - Yang, Yumei
AU - Hao, Junjie
AU - Xu, Xiahong
AU - Xiong, Xinli
AU - Tang, Yueyu
AU - Guo, Yijia
AU - Yu, Jianping
AU - Li, Shuping
AU - He, Song
AU - Mao, Fengkai
AU - Tan, Quandan
AU - Tan, Song
AU - Yu, Nengwei
AU - Xu, Ruxiang
AU - Sun, Mingwei
AU - Li, Binghu
AU - Guo, Jiang
AU - Liu, Leibo
AU - Liu, Hueiming
AU - Van Der Worp, H. Bart
N1 - Publisher Copyright:
© 2024 Massachusetts Medical Society.
PY - 2024/5/30
Y1 - 2024/5/30
N2 - Background Treatment of acute stroke, before a distinction can be made between ischemic and hemorrhagic types, is challenging. Whether very early blood-pressure control in the ambulance improves outcomes among patients with undifferentiated acute stroke is uncertain. Methods We randomly assigned patients with suspected acute stroke that caused a motor deficit and with elevated systolic blood pressure (≥150 mm Hg), who were assessed in the ambulance within 2 hours after the onset of symptoms, to receive immediate treatment to lower the systolic blood pressure (target range, 130 to 140 mm Hg) (intervention group) or usual blood-pressure management (usual-care group). The primary efficacy outcome was functional status as assessed by the score on the modified Rankin scale (range, 0 [no symptoms] to 6 [death]) at 90 days after randomization. The primary safety outcome was any serious adverse event. Results A total of 2404 patients (mean age, 70 years) in China underwent randomization and provided consent for the trial: 1205 in the intervention group and 1199 in the usual-care group. The median time between symptom onset and randomization was 61 minutes (interquartile range, 41 to 93), and the mean blood pressure at randomization was 178/98 mm Hg. Stroke was subsequently confirmed by imaging in 2240 patients, of whom 1041 (46.5%) had a hemorrhagic stroke. At the time of patients' arrival at the hospital, the mean systolic blood pressure in the intervention group was 159 mm Hg, as compared with 170 mm Hg in the usual-care group. Overall, there was no difference in functional outcome between the two groups (common odds ratio, 1.00; 95% confidence interval [CI], 0.87 to 1.15), and the incidence of serious adverse events was similar in the two groups. Prehospital reduction of blood pressure was associated with a decrease in the odds of a poor functional outcome among patients with hemorrhagic stroke (common odds ratio, 0.75; 95% CI, 0.60 to 0.92) but an increase among patients with cerebral ischemia (common odds ratio, 1.30; 95% CI, 1.06 to 1.60). Conclusions In this trial, prehospital blood-pressure reduction did not improve functional outcomes in a cohort of patients with undifferentiated acute stroke, of whom 46.5% subsequently received a diagnosis of hemorrhagic stroke. (Funded by the National Health and Medical Research Council of Australia and others.
AB - Background Treatment of acute stroke, before a distinction can be made between ischemic and hemorrhagic types, is challenging. Whether very early blood-pressure control in the ambulance improves outcomes among patients with undifferentiated acute stroke is uncertain. Methods We randomly assigned patients with suspected acute stroke that caused a motor deficit and with elevated systolic blood pressure (≥150 mm Hg), who were assessed in the ambulance within 2 hours after the onset of symptoms, to receive immediate treatment to lower the systolic blood pressure (target range, 130 to 140 mm Hg) (intervention group) or usual blood-pressure management (usual-care group). The primary efficacy outcome was functional status as assessed by the score on the modified Rankin scale (range, 0 [no symptoms] to 6 [death]) at 90 days after randomization. The primary safety outcome was any serious adverse event. Results A total of 2404 patients (mean age, 70 years) in China underwent randomization and provided consent for the trial: 1205 in the intervention group and 1199 in the usual-care group. The median time between symptom onset and randomization was 61 minutes (interquartile range, 41 to 93), and the mean blood pressure at randomization was 178/98 mm Hg. Stroke was subsequently confirmed by imaging in 2240 patients, of whom 1041 (46.5%) had a hemorrhagic stroke. At the time of patients' arrival at the hospital, the mean systolic blood pressure in the intervention group was 159 mm Hg, as compared with 170 mm Hg in the usual-care group. Overall, there was no difference in functional outcome between the two groups (common odds ratio, 1.00; 95% confidence interval [CI], 0.87 to 1.15), and the incidence of serious adverse events was similar in the two groups. Prehospital reduction of blood pressure was associated with a decrease in the odds of a poor functional outcome among patients with hemorrhagic stroke (common odds ratio, 0.75; 95% CI, 0.60 to 0.92) but an increase among patients with cerebral ischemia (common odds ratio, 1.30; 95% CI, 1.06 to 1.60). Conclusions In this trial, prehospital blood-pressure reduction did not improve functional outcomes in a cohort of patients with undifferentiated acute stroke, of whom 46.5% subsequently received a diagnosis of hemorrhagic stroke. (Funded by the National Health and Medical Research Council of Australia and others.
KW - Anticoagulation/Thromboembolism
KW - Cardiology
KW - Cardiology General
KW - Clinical Medicine
KW - Clinical Medicine General
KW - Emergency Medicine
KW - Emergency Medicine General
KW - Geriatrics/Aging
KW - Geriatrics/Aging General
KW - Hospital-Based Clinical Medicine
KW - Hypertension
KW - Neurology/Neurosurgery
KW - Neurology/Neurosurgery General
KW - Peripheral Arterial and Aortic Disease
KW - Public Health
KW - Public Health General
KW - Radiology
KW - Radiology General
KW - Stroke
UR - http://www.scopus.com/inward/record.url?scp=85194882556&partnerID=8YFLogxK
U2 - 10.1056/NEJMoa2314741
DO - 10.1056/NEJMoa2314741
M3 - Article
C2 - 38752650
AN - SCOPUS:85194882556
SN - 0028-4793
VL - 390
SP - 1862
EP - 1872
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 20
ER -